Clinical Trial Update: A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing whether SEP-363856 has physical dependence potential in adults with schizophrenia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEP-363856

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED